Isoniazid: Clinical Trials

60 trials of Isoniazid, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

35 completed, 8 unknown, 6 recruiting, 4 active not recruiting. 60 Phase 3, 13 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 360Completed 35, Unknown 8, Recruiting 6, Active not recruiting 4, Not yet recruiting 3, Terminated 3, Withdrawn 1
Phase 213Completed 8, Unknown 2, Active not recruiting 1, Recruiting 1, Terminated 1

Follow Isoniazid: new trials by email Literature Review of Isoniazid trials Research Report on Isoniazid

Trials (filtered) newest first · largest first

All 60 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Optimal Treatment Duration for Radiographically Apparent, Bacteriologically Unconfirmed TB, Identified Through Active Case Finding (RADIO-TB Trial)
Isoniazid (H), Rifampicin (R), Pyrazinamide (Z) - Tuberculosis (TB)
Phase 3RecruitingUniversity College, London7842026-10-122026-10-26
Bedaquiline Roll-out Evidence in Contacts and People Living With HIV to Prevent TB
Bedaquiline, Isoniazid, rifapentine, Levofloxacin - Tuberculosis, Latent
Phase 2 / Phase 3RecruitingJohns Hopkins University25302026-05-082026-10-20
Ultra-Short Regimen for Elderly DS-TB
Bedaquiline (B), Sitafloxacin (S), Linezolid (L) - Pulmonary Tuberculosis
Phase 3Not yet recruitingShenzhen Third People's Hospital3002025-07-252025-07-22
A PAN-USR TB Multi-Center Trial
Bedaquiline (B), Sitafloxacin (S), Linezolid (L) - Pulmonary Tuberculosis
Phase 3RecruitingShenzhen Third People's Hospital6102025-06-182025-12-01
Shortened Regimen for Drug-susceptible TB in Children
Isoniazid, Rifampin, Pyrazinamide - Tuberculosis, Tuberculosis, Pulmonary
Phase 3RecruitingJohns Hopkins University8602025-01-152026-11-12
1HP Versus 3HR in the Treatment of Tuberculosis Infection in Vietnam
Isoniazid, Rifapentine, Rifampicin - Tuberculosis Infection
Phase 3WithdrawnFreundeskreis Für Internationale Tuberkulosehilfe e.V2024-11-012026-09-09
An Adaptive Multi-arm Trial to Improve Clinical Outcomes Among Children Recovering From Complicated SAM
Rifampicin, Azithromycin, Isoniazid - Severe Acute Malnutrition, HIV
Phase 3CompletedQueen Mary University of London6742024-07-152026-08-25
Intensified Short Course Regimen for TBM in Adults
High dose rifampicin (25mg/kg), Moxifloxacin 400mg, Aspirin 150 mg - Tuberculous Meningitis
Phase 3Not yet recruitingIndian Council of Medical Research3722024-03-012023-12-21
Short-course Regimens for the Treatment of Pulmonary Tuberculosis
Rifabutin, Delamanid, Bedaquiline - Tuberculosis, Pulmonary, Tuberculosis Infection
Phase 2 / Phase 3Active not recruitingCenters for Disease Control and Prevention2882023-11-212026-09-21
A Novel Therapy With a 1-Month Ultrashort Regimen to Halt Progression From Latent Infection to Active Tuberculosis Among Close Contacts (The TB-YOUTH Study)
isoniazid and rifapentine, Rifampin and Isoniazid - Tuberculosis, Latent Tuberculosis
Phase 3RecruitingHuashan Hospital35202023-09-012026-07-14
Sitafloxacin-containing Regimens for Shortening Tuberculosis Treatment
Sitafloxacin, SMZ/TMP, Rifampin - Tuberculosis, Pulmonary
Phase 3UnknownFirst Affiliated Hospital of Zhejiang University6202022-10-012022-07-12
Safety of Administering Isoniazid to SLE Patients to Prevent TB
Isoniazid/Pyridoxine, Saccharum Lactis - Tuberculosis, Systemic Lupus Erythematosus
Phase 2 / Phase 3UnknownUniversitas Padjadjaran602022-08-152024-10-01
Preventive Treatment Of Latent Tuberculosis Infection In People With Diabetes Mellitus
Isoniazid and Rifapentine (INH-RPT), Placebo - Diabetes Mellitus, Tuberculosis
Phase 3UnknownDr. Nyanda Elias Ntinginya30002022-06-172023-03-29
Testing New Strategies for Patients Hospitalised With HIV-associated Disseminated Tuberculosis
Rifampin, Levofloxacin, Rifampicin, Pyrazinamide, Ethambutol and Isoniazid - Disseminated Tuberculosis, HIV
Phase 3Active not recruitingUniversity of Cape Town7322021-08-112026-01-06
Novel Triple-dose Tuberculosis Retreatment Regimen
6EH³R³Z, 6EHRZ - Multidrug-resistant Tuberculosis, Pulmonary Tuberculosis
Phase 3RecruitingInstitute of Tropical Medicine, Belgium3702021-03-012025-04-13
Treating Tuberculosis With the Lipid Lowering Drug Atorvastatin in Nigeria(ATORvastatin in Pulmonary TUBerculosis)
Atorvastatin with standard anti tuberculosis drugs, Standard anti tuberculosis drugs only - Tuberculosis, Pulmonary, Tuberculosis
Phase 2 / Phase 3CompletedObafemi Awolowo University Teaching Hospital1502021-01-192023-12-08
Short Course Rifapentine and Isoniazid for the Preventive Treatment for Latent Genital Tuberculosis
rifapentine plus isoniazid - Infertility, Female, Recurrent Implantation Failure
Phase 3UnknownHuashan Hospital10502020-09-012020-08-27
Treatment Shortening of Drug-Sensitive Pulmonary Tuberculosis Using High Dose Rifampicin (Hi-DoRi-3)
High-dose rifampicin, Isoniazid, Pyrazinamide - Tuberculosis, Pulmonary
Phase 3Not yet recruitingSeoul National University Hospital9262020-09-012020-07-24
Risk of SDRs Under 3HP and 1HP Regimen for LTBI
isoniazid and rifapentine - Latent Tuberculosis Infection
Phase 3CompletedNational Taiwan University Hospital4902019-09-242023-12-26
Tuberculosis Preventive Therapy Among Latent Tuberculosis Infection in HIV-infected Individuals
Isoniazid/Rifapentine daily (4 weeks) plus pyridoxine (vitamin B6), Isoniazid/Rifapentine 12-weekly plus pyridoxine (vitamin B6) - HIV-infected Participants With Latent TB Infection in High TB Burden Country
Phase 3Active not recruitingThe HIV Netherlands Australia Thailand Research Collaboration25002019-08-152026-09-16

Showing 20 of 60. Sign in to see all of them.

Conditions studied

Tuberculosis (36)  ·  Tuberculosis, Pulmonary (18)  ·  Latent Tuberculosis (11)  ·  HIV Infections (8)  ·  Tuberculosis, Multidrug-Resistant (7)  ·  Acquired Immunodeficiency Syndrome (5)  ·  AIDS-Related Opportunistic Infections (1)  ·  Child Nutrition Disorders (1)  ·  Diabetes Mellitus (1)  ·  Extensively Drug-Resistant Tuberculosis (1)  ·  Infections (1)  ·  Infertility, Female (1)  ·  Lung Diseases (1)  ·  Lupus Erythematosus, Systemic (1)  ·  Mycobacterium Infections (1)

Sponsors

Centers for Disease Control and Prevention (6)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (6)  ·  National Taiwan University Hospital (4)  ·  Tuberculosis Research Centre, India (4)  ·  University of Cape Town (4)  ·  Global Alliance for TB Drug Development (3)  ·  Huashan Hospital (3)  ·  Johns Hopkins University (2)  ·  McGill University (2)  ·  Shenzhen Third People's Hospital (2)  ·  University College, London (2)  ·  All India Institute of Medical Sciences (1)  ·  Anna Griffiths, MRC (1)  ·  Dr. Nyanda Elias Ntinginya (1)  ·  First Affiliated Hospital of Zhejiang University (1)

Countries

South Africa (17)  ·  Uganda (13)  ·  India (11)  ·  United States (9)  ·  Brazil (8)  ·  Canada (6)  ·  China (6)  ·  Kenya (6)  ·  Tanzania (6)  ·  Zimbabwe (6)  ·  Indonesia (5)  ·  Philippines (5)  ·  Taiwan (5)  ·  Thailand (5)  ·  Botswana (4)

Top investigators

Soumya Swaminathan, MD MNAMS (2)  ·  Subodh Katiyar, MD (2)  ·  Susan Swindells, MBBS (2)  ·  A K Jain, MBBS FICA (1)  ·  Alexander Pym, MB BMRCP PhD (1)  ·  Ali Zumla, BSc MBChB MSc PhD (1)  ·  Amina Jindani, MD (1)  ·  Amita Gupta, MD, MHS (1)  ·  Anchalee Avihingsanon, MD, PhD (1)  ·  Andreas Diacon, BM MD (1)  ·  Andrew Nunn, BSc MSc (1)  ·  Andrew Nunn, PhD (1)  ·  Andrey S Borisov, MD, MPH (1)  ·  Angela Crook (1)  ·  Anjula Bhargava, MS (1)

Results publications

PMID 36808186, PMID 29393655, PMID 31866327, PMID 32539440, PMID 32785709, PMID 36949623, PMID 15844071, PMID 17085459, PMID 17928422, PMID 18230259, PMID 19542476, PMID 19886982, PMID 19965813, PMID 20607114, PMID 20610636, PMID 20627913, PMID 21460373, PMID 21732833, PMID 21732834, PMID 21813327, PMID 22116143, PMID 22150035, PMID 22410137, PMID 22419641, PMID 23251327, PMID 23317958, PMID 23433590, PMID 24099345, PMID 24663014, PMID 24670570, PMID 24903787, PMID 25196020, PMID 25363329, PMID 25404412, PMID 25580725, PMID 25904367, PMID 26038418, PMID 26082504, PMID 26095067, PMID 26104205, PMID 26847437, PMID 26872154, PMID 26929418, PMID 26951571, PMID 27243774, PMID 28087928, PMID 29114781, PMID 29507938, PMID 29653915, PMID 29779774

NIH funding

R01AI048526 (1), U01AI051315 (1), U01AI068632 (1)